By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Avedro, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-768-3400 Fax: 781-768-3401


Medical Device

Company News
Avedro Receives Additional Indication For Photrexa Viscous, Photrexa And The KXL System For The Treatment Of Corneal Ectasia Following Refractive Surgery 7/19/2016 11:40:17 AM
Avedro Wins FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking 4/19/2016 6:14:12 AM
Avedro CEO Resigns; Pharma Device Maker Snags CE Mark Clearance for its Mosaic Advanced Cross-Linking System 12/28/2015 8:53:29 AM
Massachusetts' Avedro Locks in $32 Million 11/16/2015 6:13:04 AM
China Food And Drug Administration (CFDA) Grants Approval For Avedro, Inc.'s KXL System 11/3/2015 12:04:43 PM
Avedro, Inc. Resubmits New Drug Application To FDA For Corneal Cross-Linking 10/19/2015 10:12:37 AM
Avedro, Inc. Expands Patent Portfolio with Licenses From California Institute of Technology And IROC Innocross 4/14/2015 11:15:44 AM
Avedro, Inc. Announces Receipt Of Complete Response Letter From FDA For Corneal Cross-Linking NDA 3/31/2015 2:01:55 PM
Avedro, Inc. Welcomes David J. McIntyre To Its Board Of Directors 3/27/2015 10:05:48 AM
FDA Advisory Committee Recommends Approval For Avedro, Inc.’S Riboflavin Ophthalmic Solutions With UVA Irradiation For Corneal Collagen Cross-Linking To Treat Progressive Keratoconus And Corneal Ectasia 2/27/2015 10:36:39 AM